Holen Sie sich die Stockscreener-App
12.90
5.49%
-0.75
Finanzdaten der Syndax Pharmaceuticals Inc-Aktie (SNDX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
12.22%
72.79
|
64.86 | 68.73 | 45.87 | 37.96 |
| Operating Expenses |
13.85%
112.78
|
99.07 | 131.28 | 103.30 | 107.31 |
| Operating Income/Loss |
16.94%
-39.99
|
-34.20 | -62.55 | -57.43 | -69.35 |
| Nonoperating Income/Loss |
10.59%
-9.368
|
-8.471 | -5.466 | -3.289 | -2.494 |
| Income Tax Expense/Benefit |
-
|
- | 0.433 | - | - |
Net Income/Loss
|
15.68%
-49.36
|
-42.67 | -68.01 | -60.72 | -71.85 |
| Basic Average Shares |
0.83%
88.99
|
88.26 | 0.0944 | 86.62 | 86.34 |
| Diluted Average Shares |
0.83%
88.99
|
88.26 | 0.0944 | 86.62 | 86.34 |
| Basic Earnings Per Share |
14.58%
-0.55
|
-0.48 | -0.78 | -0.70 | -0.83 |
| Diluted Earnings Per Share |
14.58%
-0.55
|
-0.48 | -0.78 | -0.70 | -0.83 |
1.60%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):